Last updated at 15 Sep 2025 08:58 AM
Director
DIN: 00396716
Manu Anand is currently associated with 2 companies as Director. They serve as a Director at GLAXOSMITHKLINE PHARMACEUTICALS LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00396716.Manu Anand has previously been associated with 8 companies in roles such as Director, Alternate Director, Whole-time director, Additional Director and Managing Director.Manu Anand is currently involved in 1 different role. Their most recent position is with UNITED BREWERIES LIMITED as a Director. The first company Manu Anand was appointed to as a director was GLAXOSMITHKLINE PHARMACEUTICALS LIMITED. Manu Anand is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Manu Anand is currently associated with 2 companies as Director. They serve as a Director at GLAXOSMITHKLINE PHARMACEUTICALS LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00396716.Manu Anand has previously been associated with 8 companies in roles such as Director, Alternate Director, Whole-time director, Additional Director and Managing Director.Manu Anand is currently involved in 1 different role. Their most recent position is with UNITED BREWERIES LIMITED as a Director. The first company Manu Anand was appointed to as a director was GLAXOSMITHKLINE PHARMACEUTICALS LIMITED. Manu Anand is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (8)
4y 2m 2y 1m Interval
Company Name | Designation | Date of Appointment |
---|---|---|
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Director | 26-Jul-2022 |
UNITED BREWERIES LIMITED | Director | 10-Aug-2022 |